• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Introduction to Sulfoximine, S-methyl-S-phenyl- (CAS No. 4381-25-3)

Sulfoximine, S-methyl-S-phenyl- (CAS No. 4381-25-3) is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, characterized by its unique sulfoximine functional group and the presence of S-methyl-S-phenyl substituents, exhibits a range of intriguing chemical properties that make it a valuable candidate for various applications.

The CAS No. 4381-25-3 identifier is a critical reference point for researchers and chemists, ensuring precise identification and differentiation from other compounds with similar structures. The sulfoximine moiety is particularly noteworthy, as it imparts distinct reactivity and stability to the molecule. This feature has been leveraged in the synthesis of novel pharmaceutical agents, where the sulfoximine group often serves as a key pharmacophore.

In recent years, there has been a growing interest in sulfoximine derivatives due to their potential biological activities. The S-methyl-S-phenyl substituents contribute to the compound's solubility and metabolic stability, making it an attractive scaffold for drug design. Studies have demonstrated that sulfoximines can act as potent inhibitors of various enzymatic pathways, which has opened up new avenues for therapeutic intervention.

One of the most compelling aspects of Sulfoximine, S-methyl-S-phenyl- is its role in the development of targeted therapies. Researchers have explored its efficacy in inhibiting specific enzymes implicated in diseases such as cancer and inflammation. The compound's ability to modulate enzyme activity without significant off-target effects makes it a promising candidate for further clinical investigation.

Recent advancements in synthetic chemistry have enabled the efficient preparation of Sulfoximine, S-methyl-S-phenyl-, allowing for large-scale production and more extensive research. These improvements have been instrumental in elucidating its mechanism of action and optimizing its pharmacological properties. The compound's structural versatility also allows for modifications that can enhance its bioavailability and therapeutic efficacy.

The sulfoximine functional group is known for its ability to form stable complexes with metal ions, which has implications for applications in catalysis and material science. This property has not been extensively explored in pharmaceutical contexts but holds potential for future research. Additionally, the S-methyl-S-phenyl moiety can be further functionalized to create derivatives with tailored properties, expanding the compound's utility across multiple domains.

In conclusion, Sulfoximine, S-methyl-S-phenyl- (CAS No. 4381-25-3) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it a valuable tool for developing new therapies. As research continues to uncover new applications and refine synthetic methodologies, this compound is poised to play an increasingly important role in the advancement of medicinal chemistry.

• 33903-50-3((S)-(+)-Methyl Phenyl Sulfoximine)
• 80482-67-3(SULFOXIMINE, N,S-DIMETHYL-S-PHENYL-, (R)-)
• 33993-53-2(Methanamine,N-[(S)-methyloxidophenyl-l4-sulfanylidene]-)
• 22132-97-4(imino(methyl)(4-methylphenyl)-lambda6-sulfanone)
• 145026-07-9((4-bromophenyl)(imino)methyl-lambda6-sulfanone)
• 635311-89-6((4-fluorophenyl)(imino)methyl-λ?-sulfanone)
• 35543-41-0((4-hydroxyphenyl)(imino)methyl-lambda6-sulfanone)
• 60933-65-5((R)-(-)-S-Methyl-S-phenylsulfoximine)
• 20414-85-1(Sulfoximine,S-methyl-S-(4-methylphenyl)-, [S(R)]-)
• 22731-83-5(Sulfoximine,S,S-diphenyl-)